Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., As Chief Medical Officer
SPRO•Appointment announcement
Spero Therapeutics Inc. announced that Debra Jeske Zack, M.D., Ph.D., has been appointed as chief medical officer.
SPRO•SPRO•SPRO•Spero Therapeutics Inc. announced that Debra Jeske Zack, M.D., Ph.D., has been appointed as chief medical officer.
